[HTML][HTML] Myricetin: A review of the most recent research
X Song, L Tan, M Wang, C Ren, C Guo, B Yang… - Biomedicine & …, 2021 - Elsevier
Myricetin (MYR) is a flavonoid compound widely found in many natural plants including
bayberry. So far, MYR has been proven to have multiple biological functions and it is a …
bayberry. So far, MYR has been proven to have multiple biological functions and it is a …
The distinct roles of sialyltransferases in cancer biology and onco-immunology
M Hugonnet, P Singh, Q Haas… - Frontiers in …, 2021 - frontiersin.org
Aberrant glycosylation is a key feature of malignant transformation. Hypersialylation, the
enhanced expression of sialic acid-terminated glycoconjugates on the cell surface, has …
enhanced expression of sialic acid-terminated glycoconjugates on the cell surface, has …
Engineered models to parse apart the metastatic cascade
While considerable progress has been made in studying genetic and cellular aspects of
metastasis with in vitro cell culture and in vivo animal models, the driving mechanisms of …
metastasis with in vitro cell culture and in vivo animal models, the driving mechanisms of …
[HTML][HTML] Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies
EM Brosnan, CK Anders - Annals of translational medicine, 2018 - ncbi.nlm.nih.gov
One of the most feared sequelae after a diagnosis of advanced breast cancer is
development of metastases to the brain as this diagnosis can affect physical function …
development of metastases to the brain as this diagnosis can affect physical function …
Gangliosides: structures, biosynthesis, analysis, and roles in cancer
S Groux‐Degroote, Y Guérardel, P Delannoy - Chembiochem, 2017 - Wiley Online Library
Gangliosides are acidic glycosphingolipids containing one or more sialic acid residues.
They are essential compounds at the outer leaflet of the plasma membrane, where they …
They are essential compounds at the outer leaflet of the plasma membrane, where they …
Breast cancer brain metastasis: molecular mechanisms and directions for treatment
RMSM Pedrosa, DA Mustafa, R Soffietti… - Neuro …, 2018 - academic.oup.com
The development of brain metastasis (BM) of breast cancer is usually a late event with
deleterious effect on the prognosis. Treatment options for intracerebral seeding of breast …
deleterious effect on the prognosis. Treatment options for intracerebral seeding of breast …
Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses
D Tang, X Zhao, LI Zhang, Z Wang… - Journal of Cellular …, 2019 - Wiley Online Library
Breast cancer with metastasis especially brain metastasis represents a significant cause of
morbidity and mortality in patients. In this study, we aimed to investigate the hub genes and …
morbidity and mortality in patients. In this study, we aimed to investigate the hub genes and …
microRNAs orchestrate pathophysiology of breast cancer brain metastasis: advances in therapy
Brain metastasis (BM) predominantly occurs in triple-negative (TN) and epidermal growth
factor 2 (HER2)-positive breast cancer (BC) patients, and currently, there is an unmet need …
factor 2 (HER2)-positive breast cancer (BC) patients, and currently, there is an unmet need …
Identification and validation of a 3-gene methylation classifier for HPV-based cervical screening on self-samples
W Verlaat, BC Snoek, DAM Heideman, SM Wilting… - Clinical Cancer …, 2018 - AACR
Purpose: Offering self-sampling of cervico-vaginal material for high-risk human
papillomavirus (hrHPV) testing is an effective method to increase the coverage in cervical …
papillomavirus (hrHPV) testing is an effective method to increase the coverage in cervical …
Melanoma-secreted amyloid beta suppresses neuroinflammation and promotes brain metastasis
Brain metastasis is a significant cause of morbidity and mortality in multiple cancer types and
represents an unmet clinical need. The mechanisms that mediate metastatic cancer growth …
represents an unmet clinical need. The mechanisms that mediate metastatic cancer growth …